DILON TECHNOLOGIES INCAmended

Biotechnology · NEWPORT NEWS, VA

BiotechnologySEC Form D

DILON TECHNOLOGIES INC filed a Form D with the U.S. Securities and Exchange Commission on March 11, 2026, reporting $8,056,500 raised toward a $10,400,000 offering.

Incorporated in Delaware and based in NEWPORT NEWS, VA, it operates in the Biotechnology sector.

Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that DILON TECHNOLOGIES INC has raised capital from private investors.

Browse more recently funded companies in Biotechnology.

Executives & Directors

  • Robert G. MoussaDirector
  • Rachel F. BremDirector
  • Michael N. TaglichDirector
  • Francis BissaillonDirector
  • George N. MakhoulExecutive Officer · Director
  • Tim JetteExecutive Officer
  • Robert TaglichDirector

Recently funded in Biotechnology

Other companies that recently filed a Form D

$3.2MRaised

Goldenrod Therapeutics, Inc.

BiotechnologyHOUSTON, TX
$10.0MRaised

Human Biotech, Inc.

BiotechnologyCAMBRIDGE, MA
$1.0MRaised

Optimeos Life Sciences, Inc.

BiotechnologyPRINCETON, NJ
$2.5MRaised

BioStem Technologies, Inc.

BiotechnologyPOMPANO BEACH, FL
$10.0MRaised

Senti Biosciences Holdings, Inc.

BiotechnologySouth San Francisco, CA
DILON TECHNOLOGIES INC raised $8.1M — SEC Form D